Clinical Trials Browser

OTHER × Carcinoma, Transitional Cell × vandetanib × Clear all

NCT00880334 2018-09-18

Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC

Phase 2 Completed

149 enrolled 12 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell